Jayex Healthcare Ltd. | Cash Flow

Fiscal year is January-December. All values AUD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
349.50
859.70
5,063.00
2,496.00
1,125
Depreciation, Depletion & Amortization
-
5.50
791.00
518.00
543
Other Funds
-
69.80
2,337.00
141.00
738
Funds from Operations
349.50
784.30
2,209.00
1,938.00
41
Changes in Working Capital
237.80
391.10
76.00
403.00
791
Net Operating Cash Flow
111.60
393.30
2,285.00
2,341.00
750
Capital Expenditures
-
-
184.00
240.00
Net Investing Cash Flow
-
-
1,380.00
240.00
Issuance/Reduction of Debt, Net
112.10
5.90
567.00
2,285.00
Net Financing Cash Flow
112.10
421.90
567.00
2,285.00
Net Change in Cash
0.50
28.60
3,303.00
319.00
Free Cash Flow
111.70
393.30
2,301.00
2,358.00
Deferred Taxes & Investment Tax Credit
-
-
274.00
101.00
115
Net Assets from Acquisitions
-
-
1,196.00
-
Change in Capital Stock
-
416.00
-
-
Exchange Rate Effect
-
-
205.00
23.00

About Jayex Healthcare

View Profile
Address
17B Cribb Street
Milton Queensland (QLD) 4064
Australia
Employees -
Website http://www.jayex.com
Updated 07/08/2019
Jayex Healthcare Ltd. owns and operates healthcare service delivery technology platforms. The firm's products include Appointuit, Enlighten, p2u, and BluePoint. It also develops integrated dispensing automation systems for the pharmaceutical and healthcare sectors.